To get more information on Blood Testing Market - Request Sample Report
The Blood Testing Market was valued at USD 91.43 billion in 2023 and is expected to reach USD 169.15 billion by 2032 and grow at a CAGR of 7.08% over the forecast period 2024-2032.
Increased medical expenditure from government and regulatory bodies has highly contributed to the growth in the blood testing market. The bodies have been encouraging patients to undergo regular diagnostic tests, thereby increasing the demand for services in the blood testing sector in the forecasted period. Moreover, the research activities undertaken in developed countries have also emerged as a significant contributor to this growth. For example, scientists at the National Center for Global Health and Medicine in Japan found a blood test that can offer even early signs of severe cases of COVID-19. The viability of such tests was proven by the issuance of 500 prototype machines. Ventures such as these are becoming pivotal to pushing the regional market in Asia forward.
The rising prevalence of infectious diseases such as blood and bloodstream infections further accelerates the growth of this market. These diseases are among the top killers and pathogens causing morbidity worldwide. Blood culture tests are major diagnostic tools for pathogen detection behind conditions such as sepsis. As stated by the International Labour Organization, blood-borne diseases like HIV infect 34 million people worldwide with 69% cases in Sub-Saharan Africa. This appalling prevalence will only grow the demand for blood culture testing in the future years.
Blood test prescriptions are rapidly changing with the advancement of diagnostic technologies and growing emphasis on personalized medicine. More and more doctors prescribe routine blood tests to maintain chronic conditions as well as prophylactic measures and early detection of diseases, and monitor the response to treatments. The biggest prescription increases have been noted in advanced blood tests like molecular diagnostics, genetic screening, and liquid biopsy techniques for non-invasive cancer diagnosis. Continuous glucose monitoring systems are very commonly prescribed as a part of diabetes management, giving real-time insight into blood glucose levels. Blood biomarker tests for personalizing treatment of cardiovascular diseases, cancer, and autoimmune disorders are increasingly used. Advanced diagnostic tools are becoming more accessible, yet the use of these tests is moving towards much more frequent, personalized, and even more precise measurements of blood.
Due to advancements in telemedicine and these services being offered at a pretty affordable cost with much convenience for patients, home sample collection for blood tests has gained much popularity. Under this service, samples are collected from patients at their homes; thereby avoiding visits to clinics or labs for blood sample collection. Samples are collected by phlebotomists who are well-trained healthcare professionals while coming to the patient's home for sample collection.
Another thing is home blood drawing kits. Now, people can withdraw minute quantities of blood through a prick from their fingers. Such tests include glucose and cholesterol levels, hormone levels, and even antibodies for COVID-19. Many businesses such as LabCorp and Everlywell offer services that help people receive treatment from the comfort of their homes, especially the aged and sickly or in remote areas. Results are then made available to the patients online while permitting them follow-up consultations with their healthcare providers in due time.
|
Provider Name |
Services Offered |
Coverage Area |
Key Features |
|---|---|---|---|
|
LabCorp |
Home blood sample collection for various tests including COVID-19, cholesterol, and glucose testing. |
USA |
Mobile phlebotomy services and mail-in test kits |
|
Quest Diagnostics |
At-home blood collection for routine and specialized tests, including hormone and vitamin levels. |
USA |
Online scheduling, home visits by professionals |
|
Everlywell |
At-home blood collection kits for various tests such as cholesterol, hormones, and food sensitivity. |
USA |
Finger-prick sample collection kits |
|
LetsGetChecked |
At-home testing kits for cholesterol, thyroid, liver function, and more. |
USA, Europe |
Free shipping, telehealth consultations |
|
Thyrocare |
Home sample collection for comprehensive health checkups, including blood glucose and lipid profiles. |
India |
Affordable pricing, online reports |
|
Healthians |
Home sample collection for tests like CBC, liver function, kidney function, and more. |
India |
Real-time test tracking, free home collection |
|
Medlife |
Home blood collection for a wide range of diagnostic tests, including diabetes and thyroid screening. |
India |
Convenient online booking, and mobile app services |
|
Zoylo |
Home blood sample collection for preventive health checkups and diagnostic tests. |
India |
Multiple lab partnerships, online results |
|
Dr. Lal PathLabs |
Home blood sample collection for diagnostic and preventive tests including diabetes and lipid profiles. |
India |
Nationwide presence, online report access |
Drivers
The Surge of Chronic Diseases and Technological Innovations Fueling Growth in the Global Blood Testing Market
The increasing prevalence of chronic diseases, including diabetes, cardiovascular diseases, and cancer, distinctly propels the advancement of the global blood testing market. WHO statistics reveal that nearly 60% of all deaths are attributed to chronic diseases. Cardiovascular diseases are responsible for approximately 17.9 million deaths annually. There has been an absolute surge in the prevalence of chronic diseases. Therefore, regular blood tests are always required for early diagnosis and appropriate management. For example, diabetic management would involve frequent blood glucose level monitoring and, a highly increasing demand for blood testing devices.
Furthermore, cancer diagnosis and treatment often require a series of blood tests that monitor patients' health and mark the improvement or deterioration of their health. A recent boom in personalized medicine relies on blood biomarkers to provide customized treatments tailored for specific patients hence increasing demand. Other technologies that can be associated with growth in the market include novel blood-testing technologies, such as liquid biopsies for non-invasive cancer detection. These offer less invasive and faster methods that are more accurate and hence result in more frequent and earlier diagnoses of diseases. In all, the main rising ingredients include chronic diseases, which are on the rise; therefore, the need for further observation; and, in addition, the ever-changing technological advancements associated with blood testing that help establish a firm foundation for expansion in this blood testing market.
Restraints
Cost and Regulatory Hurdles
By Type
The glucose testing segment dominated the blood testing market in 2023. It accounted for a share of revenue at 16.6%. The main reason for this dominance is because of the widespread use of these tests all over the world. Over the past few years, diabetes has been increasing in incidence, and this is expected to grow further in the coming years. A report from the International Diabetes Federation published in December 2021 states that, in 2021, about 537 million adults aged between 20 and 79 lived with diabetes. This number is expected to grow even further to as much as 783 million by 2045, creating a lot of need for blood glucose testing, and therefore, calls for growth in this market.
The advancement of technological features in glucometers, such as Bluetooth connectivity and wireless capabilities, has made the products used even more significantly. Of special interest in the smart glucose monitoring devices list include Dario Health Smart Meter, iHealth Align, iHealth Smart, and Glooko. Service companies offering commercial services for this industry include Mayo Clinic, LabCorp America, and Quest Diagnostics. Consumables to go along with conducting glucose tests include test strips, lancets, syringes, and diabetes testing kits.
The A1C testing market is also expected to witness significant growth over the forecast period. A1C testing, also known as glycated hemoglobin testing, is foreseen to gain substantially due to its convenience. This blood test is critical for understanding average levels of blood sugar. Thus, it is used in the diagnosis and monitoring of treatment of diabetes. In addition, A1C tests are specifically beneficial for point-of-care applications in terms of long-term assessment of blood sugar control.
There are also a variety of rapid or over-the-counter (OTC) tests, as well as prescription tests, using point-of-care (POC) testing devices that measure blood glycated sugar levels. The blood test market in the world has gained steam with the outbreak of the SARS-CoV-2 virus, making many significant players develop or launch serology tests and COVID-19 antibody tests using a sample of blood from suspected patients. Established players like bioMérieux SA, Biocan Diagnostics, Inc., Beckman Coulter, Inc., Abbott Laboratories, Bio-Rad Laboratories, Inc., and Cellex, Inc. have been instrumental in crafting this segment into shape, as it developed an excellent market presence for its products.
In 2023, North America dominated the blood testing market with a share of more than 43.1%. Strategic initiatives from government entities and major market participants to promote plasma donations are expected to fuel growth in this region. Blood donation centers across the country are increasingly focusing on increasing plasma collection from people who have recovered from illnesses. This regional growth is being driven by new government initiatives, advancements in healthcare infrastructure, and various technological innovations. Several regulatory bodies, including the FDA as well as the Federal Trade Commission, play a huge role in regulating diagnostic tests. Implementation of Clinical Laboratory Improvement Amendments is expected to increase the use of testing services in the United States.
The Asia Pacific region will exhibit the highest CAGR during the forecast period, mainly due to a high chronic disease prevalence in countries like China and India. Besides, many multinational companies are heavily investing in this region. For instance, in October 2021, Siemens Healthineers announced its new facility for manufacturing in India dedicated to COVID-19 and molecular assays. A facility in Gujarat will create antigen and antibody (serology) tests, as well as RT-PCR tests for COVID-19.
Need any Customization research on Blood Testing Market - Enquiry Now
Key Players
Danaher Corporation (DxH 520 Hematology Analyzer)
Trinity Biotech Plc (Uni-Gold HIV Test, Hemoglobin A1c Testing Systems)
Roche Diagnostics (Cobas 8000 Analyzer)
bioMerieux SA (VITEK 2)
Quest Diagnostics (Quest Diabetes Panel)
Abbott (Abbott Alinity, FreeStyle Libre)
F. Hoffmann-La Roche AG (Elecsys)
Bio-Rad Laboratories, Inc. (BioPlex 2200)
Biomerica, Inc. (Hemoglobin A1c Test, Rapid Test Kits)
Becton, Dickinson and Company (BD Vacutainer, BD FACS)
Siemens Healthineers (Atellica, ADVIA)
Thermo Fisher Scientific (Orion Star A Series, Cell & Gene Therapy Kits), and others.
Recent Developments
In Sept 2024, A hospital in Coimbatore (India) implemented robotic automation for blood testing, marking a significant advancement in its diagnostic capabilities.
In April 2024, BD (Becton, Dickinson, and Company) launched its BD Vacutainer UltraTouch Push Button Blood Collection Set in India. This innovative collection set features BD RightGauge technology, enabling the use of a finer needle for blood collection, along with BD's proprietary PentaPoint Technology.
In March 2023, Guardant Health Inc. submitted the final module of its premarket approval (PMA) application for Shield, its blood test designed for colorectal cancer (CRC) screening, to the U.S. Food and Drug Administration (FDA).
In March 2023, TruDiagnostic, a health data organization, partnered with NADMED, a Finnish company focused on nicotinamide adenine dinucleotide diagnostics. This collaboration aims to launch an innovative diagnostic test kit known as Q-NADMED, designed to measure NAD+ and NADH levels in blood samples.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 91.43 Billion |
| Market Size by 2032 | USD 169.15 Billion |
| CAGR | CAGR of 7.08% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Test Type (Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin D Testing, Thyroid-stimulating Hormone (TSH), Serum Nicotine/Cotinine, High-sensitivity CRP Testing, Testosterone Testing, ALT Testing, Cortisol Testing, Creatinine Testing, AST Testing, Other Blood Tests) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia-Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia-Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Danaher Corporation, Trinity Biotech Plc, Roche Diagnostics, bioMerieux SA, Quest Diagnostics, Abbott, Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Biomerica, Inc., Becton, Dickinson and Company, Siemens Healthineers, Thermo Fisher Scientific, and Others |
| Key Drivers | • The Surge of Chronic Diseases and Technological Innovations Fueling Growth in the Global Blood Testing Market |
| Restraints | • Cost and Regulatory Hurdles |
Ans: The Blood Testing Market is to grow at a CAGR of 7.08% over the forecast period 2024-2031
Ans: The Blood Testing Market size was valued at USD 91.43 billion in 2023.
The Surge of Chronic Diseases and Technological Innovations is the main driver for the blood testing market.
The market for Blood Testing was dominated by North America.
Manufacturer and service provider, research institutes, universities, and private libraries, suppliers, and distributors.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Device Volume, by Region (2020-2032)
5.4 Healthcare Spending, by Region, (Government, Commercial, Private, Out-of-Pocket), 2023
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Blood Testing Market Segmentation, by Test Type
Chapter Overview
7.2 Glucose Testing
7.2.1 Glucose Testing Market Trends Analysis (2020-2032)
7.2.2 Glucose Testing Market Size Estimates and Forecasts to 2032 (USD Million)
7.3 A1C Testing
7.3.1 A1C Testing Market Trends Analysis (2020-2032)
7.3.2 A1C Testing Market Size Estimates and Forecasts to 2032 (USD Million)
7.4 Direct LDL Testing
7.4.1 Direct LDL Testing Market Trends Analysis (2020-2032)
7.4.2 Direct LDL Testing Market Size Estimates and Forecasts to 2032 (USD Million)
Lipid Panel Testing
7.5.1 Lipid Panel Testing Market Trends Analysis (2020-2032)
7.5.2 Lipid Panel Testing Market Size Estimates and Forecasts to 2032 (USD Million)
7.6 Prostate-specific Antigen Testing
7.6.1 Prostate-specific Antigen Testing Market Trends Analysis (2020-2032)
7.6.2 Prostate-specific Antigen Testing Market Size Estimates and Forecasts to 2032 (USD Million)
7.7 COVID-19 Testing
7.7.1 COVID-19 Testing Market Trends Analysis (2020-2032)
7.7.2 COVID-19 Testing Market Size Estimates and Forecasts to 2032 (USD Million)
7.8 BUN Testing
7.8.1 BUN Testing Market Trends Analysis (2020-2032)
7.8.2 BUN Testing Market Size Estimates and Forecasts to 2032 (USD Million)
7.9 Vitamin D Testing
7.9.1 Vitamin D Testing Market Trends Analysis (2020-2032)
7.9.2 Vitamin D Testing Market Size Estimates and Forecasts to 2032 (USD Million)
7.10 Thyroid-stimulating Hormone (TSH)
7.10.1 Thyroid-stimulating Hormone (TSH)Market Trends Analysis (2020-2032)
7.10.2 Thyroid-stimulating Hormone (TSH)Market Size Estimates and Forecasts to 2032 (USD Million)
7.11 Serum Nicotine/Cotinine
7.11.1 Serum Nicotine/Cotinine Market Trends Analysis (2020-2032)
7.11.2 Serum Nicotine/Cotinine Market Size Estimates and Forecasts to 2032 (USD Million)
7.12 High-sensitivity CRP Testing
7.12.1 High-sensitivity CRP Testing Market Trends Analysis (2020-2032)
7.12.2 High-sensitivity CRP Testing Market Size Estimates and Forecasts to 2032 (USD Million)
7.13 Testosterone Testing
7.13.1 Testosterone Testing Market Trends Analysis (2020-2032)
7.13.2 Testosterone Testing Market Size Estimates and Forecasts to 2032 (USD Million)
7.14 ALT Testing
7.14.1 ALT Testing Market Trends Analysis (2020-2032)
7.14.2 ALT Testing Market Size Estimates and Forecasts to 2032 (USD Million)
7.15 Cortisol Testing
7.15.1 Cortisol Testing Market Trends Analysis (2020-2032)
7.15.2 Cortisol Testing Market Size Estimates and Forecasts to 2032 (USD Million)
7.16 Creatinine Testing
7.16.1 Creatinine Testing Market Trends Analysis (2020-2032)
7.16.2 Creatinine Testing Market Size Estimates and Forecasts to 2032 (USD Million)
7.17 AST Testing
7.17.1 AST Testing Market Trends Analysis (2020-2032)
7.17.2 AST Testing Market Size Estimates and Forecasts to 2032 (USD Million)
7.18 Other Blood Tests
7.18.1 Other Blood Tests Market Trends Analysis (2020-2032)
7.18.2 Other Blood Tests Market Size Estimates and Forecasts to 2032 (USD Million)
8. Regional Analysis
8.1 Chapter Overview
8.2 North America
8.2.1 Trends Analysis
8.2.2 North America Blood Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
8.2.3 North America Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.2.2 USA
8.2.2.1 USA Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.2.3 Canada
8.2.3.1 Canada Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.2.4 Mexico
8.2.4.1 Mexico Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.3 Europe
8.3.1 Eastern Europe
8.3.1.1 Trends Analysis
8.3.1.2 Eastern Europe Blood Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
8.3.1.3 Eastern Europe Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.3.1.4 Poland
8.3.1.4.1 Poland Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.3.1.5 Romania
8.3.1.5.1 Romania Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.3.1.6 Hungary
10.3.1.8.1 Hungary Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.3.1.7 Turkey
8.3.1.7.1 Turkey Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.3.1.8 Rest of Eastern Europe
8.3.1.8.1 Rest of Eastern Europe Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.3.2 Western Europe
8.3.2.1 Trends Analysis
8.3.2.2 Western Europe Blood Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
8.3.2.3 Western Europe Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.3.2.4 Germany
8.3.2.4.1 Germany Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.3.2.5 France
8.3.2.5.1 France Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.3.2.6 UK
8.3.2.6.1 UK Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.3.2.7 Italy
8.3.2.7.1 Italy Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.3.2.8 Spain
8.3.2.8.1 Spain Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.3.2.9 Netherlands
8.3.2.9.1 Netherlands Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.3.2.10 Switzerland
8.3.2.10.1 Switzerland Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.3.2.11 Austria
8.3.2.11.1 Austria Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.3.2.12 Rest of Western Europe
8.3.2.12.1 Rest of Western Europe Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.4 Asia Pacific
8.4.1 Trends Analysis
8.4.2 Asia Pacific Blood Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
8.4.3 Asia Pacific Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.4.4 China
8.4.4.1 China Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.4.5 India
8.4.5.1 India Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.4.6 Japan
8.4.6.1 Japan Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.4.7 South Korea
8.4.7.1 South Korea Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.4.8 Vietnam
8.4.8.1 Vietnam Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.4.9 Singapore
8.4.9.1 Singapore Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.4.10 Australia
8.4.10.1 Australia Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.4.11 Rest of Asia Pacific
8.4.11.1 Rest of Asia Pacific Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.5 Middle East and Africa
8.5.1 Middle East
8.5.1.1 Trends Analysis
8.5.1.2 Middle East Blood Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.5.1.3 Middle East Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.5.1.4 UAE
8.5.1.4.1 UAE Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.5.1.5 Egypt
8.5.1.5.1 Egypt Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.5.1.6 Saudi Arabia
8.5.1.6.1 Saudi Arabia Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.5.1.7 Qatar
8.5.1.7.1 Qatar Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.5.1.8 Rest of Middle East
8.5.1.8.1 Rest of Middle East Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.5.2 Africa
8.5.2.1 Trends Analysis
8.5.2.2 Africa Blood Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
8.5.2.3 Africa Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.5.2.4 South Africa
8.5.2.4.1 South Africa Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.5.2.5 Nigeria
8.5.2.5.1 Nigeria Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.5.2.6 Rest of Africa
8.5.2.6.1 Rest of Africa Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.6 Latin America
8.6.1 Trends Analysis
8.6.2 Latin America Blood Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
8.6.3 Latin America Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.6.4 Brazil
8.6.4.1 Brazil Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.6.5 Argentina
8.6.5.1 Argentina Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.6.6 Colombia
8.6.6.1 Colombia Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
8.6.7 Rest of Latin America
8.6.7.1 Rest of Latin America Blood Testing Market Estimates and Forecasts, by Test Type (2020-2032) (USD Million)
9. Company Profiles
9.1 Danaher Corporation
9.1.1 Company Overview
9.1.2 Financial
9.1.3 Products/ Services Offered
9.1.4 SWOT Analysis
9.2 Trinity Biotech Plc
9.2.1 Company Overview
9.2.2 Financial
9.2.3 Products/ Services Offered
9.2.4 SWOT Analysis
9.3 Roche Diagnostics
9.3.1 Company Overview
9.3.2 Financial
9.3.3 Products/ Services Offered
9.3.4 SWOT Analysis
9.4 bioMerieux SA
9.4.1 Company Overview
9.4.2 Financial
9.4.3 Products/ Services Offered
9.4.4 SWOT Analysis
9.5 Quest Diagnostics
9.5.1 Company Overview
9.5.2 Financial
9.5.3 Products/ Services Offered
9.5.4 SWOT Analysis
9.6 Abbott
9.6.1 Company Overview
9.6.2 Financial
9.6.3 Products/ Services Offered
9.6.4 SWOT Analysis
9.7 F. Hoffmann-La Roche AG
9.7.1 Company Overview
9.7.2 Financial
9.7.3 Products/ Services Offered
9.7.4 SWOT Analysis
9.8 Biomerica, Inc.
9.8.1 Company Overview
9.8.2 Financial
9.8.3 Products/ Services Offered
9.8.4 SWOT Analysis
9.9 Bio-Rad Laboratories, Inc.
9.9.1 Company Overview
9.9.2 Financial
9.9.3 Products/ Services Offered
9.9.4 SWOT Analysis
9.10 Thermo Fisher Scientific
9.10.1 Company Overview
9.10.2 Financial
9.10.3 Products/ Services Offered
9.10.4 SWOT Analysis
10. Use Cases and Best Practices
11. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segmentation
By Test Type
Glucose Testing
A1C Testing
Direct LDL Testing
Lipid Panel Testing
Prostate-specific Antigen Testing
COVID-19 Testing
BUN Testing
Vitamin D Testing
Thyroid-stimulating Hormone (TSH)
Serum Nicotine/Cotinine
High-sensitivity CRP Testing
Testosterone Testing
ALT Testing
Cortisol Testing
Creatinine Testing
AST Testing
Other Blood Tests
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Nuclear Imaging Equipment Market was valued at USD 3.78 billion in 2023, and it is expected to reach USD 5.32 billion by 2032, registering a CAGR of 3.87% from 2024 to 2032.
The Sexual Health Products Market Size was valued at USD 118.83 Billion in 2023, and is expected to reach USD 243.83 Billion by 2032, and grow at a CAGR of 8.71% over the forecast period 2024-2032.
The Vitamins Market Size was valued at USD 7.41 billion in 2023 and is expected to reach USD 13.39 billion by 2031 and grow at a CAGR of 7.67% by 2024 -2031
The Dental X-Ray Market Size was valued at USD 2.30 billion in 2023, and is expected to reach USD 4.58 billion by 2031 and grow at a CAGR of 9% over the forecast period 2024-2031.
The Healthcare Analytics Market was USD 43.05 billion by 2023 and growing at a CAGR of 21.2% from 2024 to 2031 and will reach USD 200.44 billion by 2031.
The Oxytocic Pharmaceuticals Market Size was valued at USD 114.57 Million in 2023 and is expected to reach USD 210.49 Million by 2031, and grow at a CAGR of 7.9% over the forecast period 2024-2031.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
